Compare ProShares Ultra Semiconductors (USD) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra Semiconductors vs 22nd Century Group Inc — how do they compare? ProShares Ultra Semiconductors trades at $90.2, while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). Which is the better fit depends on your goals.
| USD | XXII | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $113.53 | $1.07K |
52-Week Low | $39.58 | $3.90 |
Market Cap | — | $1.49M |
Enterprise Value | — | -$6.74M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
USD stock trades at $83.24, up 1.19% with a bearish technical signal from moving averages. The company shows limited financial data availability, with key valuation and profitability ratios not provided. Recent corporate actions include a future dividend announcement for June 2026. Technical indicators show neutral oscillators but bearish momentum signals with support at $82 and resistance at $86.
The outlook remains cautious due to bearish technical indicators and incomplete fundamental data. Investment opportunities depend on forthcoming financial disclosures, while risks include market volatility and the stock's current technical weakness. The neutral sentiment from oscillators suggests potential stabilization near current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
